A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study in Healthy Volunteers and Patients With Chronic Hepatitis C Viral Infection to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANA773 Tosylate.
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2012
At a glance
- Drugs RG 7795 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 30 Sep 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 30 Sep 2010 Actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Results were reported in an Anadys Pharmaceuticals media release and will be presented at the Annual Meeting of the American Association for the Study of Liver Diseases.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History